Paper41752014
Role of NADPH Oxidases as Novel Therapeutic Targets for the Impaired Neurovascular Unit in the Early Stage of Diabetic Retinopathy.
Dionysopoulou S and 1 other. Int J Mol Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Role of NADPH Oxidases as Novel Therapeutic Targets for the Impaired Neurovascular Unit in the Early Stage of Diabetic Retinopathy. Papers, record 41752014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41752014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of NADPH Oxidases as Novel Therapeutic Targets for the Impaired Neurovascular Unit in the Early Stage of Diabetic Retinopathy.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Retinopathy | Major topic |
| NADPH Oxidases | Major topic |
| Humans | |
| Animals | |
| Oxidative Stress | |
| Reactive Oxygen Species | |
| Molecular Targeted Therapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ELKE KA 10752 to K.T. | This research was funded by a grant from the University of Crete (ELKE KA 10752 to K.T.) and a donation from Glucox Biotech AB to University of Crete (ELKE KA 10879 to K.T.) and the Christina Spyraki award to S.D. The funders had no role in the design of | PubMed |
Source PubMed
References147
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25975734 | Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. | Prog Retin Eye Res | 2015 | https://conductscience.org/library/papers/25975734 | PubMed |
| 2 | 21635964 | Inflammation in diabetic retinopathy. | Prog Retin Eye Res | 2011 | https://conductscience.org/library/papers/21635964 | PubMed |
| 3 | 15855346 | Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. | Diabetes | 2005 | https://conductscience.org/library/papers/15855346 | PubMed |
| 4 | 15914466 | The blood-brain barrier/neurovascular unit in health and disease. | Pharmacol Rev | 2005 | https://conductscience.org/library/papers/15914466 | PubMed |
| 5 | 9867208 | Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine. | Diabetologia | 1998 | https://conductscience.org/library/papers/9867208 | PubMed |
| 6 | 32231131 | Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32231131 | PubMed |
| 7 | 36637915 | Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years. | Diabetes Care | 2023 | https://conductscience.org/library/papers/36637915 | PubMed |
| 8 | 22118627 | Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury. | J Neurochem | 2012 | https://conductscience.org/library/papers/22118627 | PubMed |
| 9 | 22648375 | The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. | Cell Mol Life Sci | 2012 | https://conductscience.org/library/papers/22648375 | PubMed |
| 10 | 30806815 | Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies. | Curr Diab Rep | 2019 | https://conductscience.org/library/papers/30806815 | PubMed |
| 11 | 8757258 | Ca(2+)-permeable AMPA/kainate and NMDA channels: high rate of Ca2+ influx underlies potent induction of injury. | J Neurosci | 1996 | https://conductscience.org/library/papers/8757258 | PubMed |
| 12 | 26297071 | The progress in understanding and treatment of diabetic retinopathy. | Prog Retin Eye Res | 2016 | https://conductscience.org/library/papers/26297071 | PubMed |
| 13 | 1970230 | The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. | Annu Rev Neurosci | 1990 | https://conductscience.org/library/papers/1970230 | PubMed |
| 14 | 17275103 | Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. | Trends Neurosci | 2007 | https://conductscience.org/library/papers/17275103 | PubMed |
| 15 | 31847599 | Structural and Functional Abnormalities in Early-stage Diabetic Retinopathy. | Curr Eye Res | 2020 | https://conductscience.org/library/papers/31847599 | PubMed |
| 16 | 28545893 | Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment. | J Diabetes Complications | 2017 | https://conductscience.org/library/papers/28545893 | PubMed |
| 17 | 17713594 | A role for excitatory amino acids in diabetic eye disease. | Exp Diabetes Res | 2007 | https://conductscience.org/library/papers/17713594 | PubMed |
| 18 | 34944680 | Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells. | Biomedicines | 2021 | https://conductscience.org/library/papers/34944680 | PubMed |
| 19 | 34452281 | Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34452281 | PubMed |
| 20 | 38543179 | Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38543179 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42866040 | Diabetic retinal neurovascular unit injury: mechanisms, imaging evaluation, and integrated therapeutic strategies. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42866040 |
Source PubMed
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41752014
GET https://conductscience.org/api/papers/v1/41752014/references?page=2